Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04844541 · ClinicalTrials.gov registry record
Prophylaxis and Treatment of COVID-19
A clinical trial of COVID-19 and Acute Respiratory Infection, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- Completed
- Registry status
- 450
- Enrollment target
- 3
- Study locations
NCT04844541 is a study of COVID-19 and Acute Respiratory Infection that has completed, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 450 participants, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT04844541, a study of COVID-19 and Acute Respiratory Infection, has completed, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- COMPLETED
- Registry status
- 450 participants
- Enrollment target
- 3
- Study locations
Study Summary
An observation study evaluating physiologic responses and host biomarker expression patterns in early SARS-CoV-2 and acute respiratory infections (ARI) and among their close contacts.
Conditions Studied
Study Locations (3)
Maryland
- Johns Hopkins University - Baltimore
North Carolina
- Duke Global Health Institute - Durham
Other
- Royal Thai Army Clinical Research Center (RTA CRC)/Royal Thai Army-Armed Forces Research Institute of Medical Sciences (RTA-AFRIMS)/Phramongkutklao Hospital - Bangkok
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2021-06-11 |
| Est. Completion | 2024-02-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04844541
The ClinicalTrials.gov registry entry for NCT04844541 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 0 interventions.
NCT04844541 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Maryland, North Carolina, Other.
Frequently Asked Questions
What is clinical trial NCT04844541 about?
NCT04844541 is a clinical study titled "Prophylaxis and Treatment of COVID-19". An observation study evaluating physiologic responses and host biomarker expression patterns in early SARS-CoV-2 and acute respiratory infections (ARI) and among their close contacts.
What is the current status of trial NCT04844541?
This trial is currently completed. The enrollment target is 450 participants. The study started on 2021-06-11. Estimated completion is 2024-02-21.
What conditions does trial NCT04844541 study?
This clinical trial studies the following conditions: COVID-19, Acute Respiratory Infection.
Who is sponsoring clinical trial NCT04844541?
This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04844541 being conducted?
This trial has 3 study locations across Maryland, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.